SNSE/ABBVCL (SNSE/ABBVCL)

Santiago Stock Exchange: SNSE/ABBVCL · CLP

CLP 285,100

+7550.00 (+2.7%)· Recorded snapshot

Market cap	497T
Revenue (ttm)	59.3T
Net income (ttm)	5.8T
EPS (ttm)	CLP 3,490
P/E (trailing)	81.7x
P/E (forward)	19.1x
Dividend	CLP 6,367 (2.23%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 59.3T
Net income (ttm): 5.8T
EPS (ttm): CLP 3,490
P/E (trailing): 81.7x
P/E (forward): 19.1x
Market cap: 497T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E81.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All SNSE/ABBVCL indicators

Market & fundamental data

Available fields

221

Groups with data

Currency

USD

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-30
Employees	57,000
Employees change	5,000
Employees growth	10%
Enterprise value	CLP 560.2T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US00287Y1091
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Market cap	CLP 497T
Next earnings date	2026-10-30
Price	CLP 285,100.00
Price currency	CLP
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-27
Symbol	snse/ABBVCL
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.22%
EV/Earnings	96.98x
EV/EBIT	24.92x
EV/EBITDA	18.31x
EV/FCF	33.39x
EV/Sales	8.86x
FCF / EV yield	2.99%
FCF yield	3.38%
Forward P/E	19.06x
Lynch fair value	CLP 16,567.50
Lynch upside	-94.19%
P/(FCF - SBC) ratio	31.3x
P/(OCF - SBC) ratio	29.11x
P/E ratio	81.68x
P/FCF ratio	29.63x
P/OCF ratio	27.66x
P/S ratio	8.38x
Price/EBITDA ratio	17.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	26.43%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	CLP 101.3M
Profitable quarters	6
Profitable years	17
Revenue per employee	CLP 1B
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CLP -1.2T
Depreciation and amortization	CLP 7.8T
EBIT	CLP 21.1T
EBITDA	CLP 28.3T
EPS	CLP 3,490.29
Financing cash flow	CLP -11.9T
Free cash flow	CLP 16.8T
Free cash flow minus SBC	CLP 15.9T
Gross profit	CLP 43.2T
Income taxes	CLP 2.2T
Investing cash flow	CLP -6T
Net borrowing	CLP 412.2B
Net cash flow	CLP 94B
Net income	CLP 5.8T
Operating cash flow minus SBC	CLP 17.1T
Operating income	CLP 21.1T
Revenue	CLP 59.3T
Stock-based compensation	CLP 899.2B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	CLP -3,094.34
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	CLP 35T
Interest coverage	7.85
Long-term assets	CLP 91.3T
Long-term liabilities	CLP 88.8T
Net cash (debt)	CLP -59.3T
Net cash / market cap	-11.92%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	CLP 5.7T
Shareholders' equity	CLP -5.4T
Tangible book value	CLP -83.5T
Tangible book value per share	CLP -47,232.63
Total assets	CLP 124.5T
Total cash	CLP 6.1T
Total debt	CLP 65.3T
Total liabilities	CLP 129.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	CLP 33.2T
Current liabilities	CLP 41.1T
Current ratio	0.81
Inventory turnover	3.47
Net working capital	CLP -5.7T
Quick ratio	0.49
Working capital	CLP -7.3T
Working capital turnover	-6,420.13

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	-0.52%
Dividend growth years	2
Dividend payment date	2026-11-16
Dividend payment years	4
Dividend payout frequency	Quarterly
Dividend per share	CLP 6,366.78
Dividend yield	2.23%
Ex-dividend date	2026-10-15
Last dividend	CLP 1,707.18
Payout ratio	189.83%
Shareholder yield	2.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CLP 205,943.47
1D price change	2.72%
1M price change	13.23%
1M total return	13.96%
1W price change	5.95%
1W total return	5.95%
1Y price change	66.15%
1Y return CAGR	71.9%
1Y total return	71.84%
20-day SMA	CLP 266,940.50
200-day SMA	CLP 197,355.10
3M price change	20.6%
3M total return	21.37%
50-day SMA	CLP 251,131.80
50-day SMA vs 200-day SMA	50over200
52-week high	CLP 285,100.00
52-week high date	2026-10-27
52-week low	CLP 171,590.00
52-week low date	2026-07-20
6M price change	66.15%
6M total return	68.79%
All-time high	CLP 285,100.00
All-time high date	2026-10-27
All-time low	CLP 165,000.00
All-time low date	2025-04-21
Average true range (ATR)	CLP 1,807.42
Average volume	0
Change from 52-week high	0%
Change from 52-week low	66.15%
Change from all-time high	0%
Change from all-time low	72.79%
Monthly RSI	95.76
Previous close	CLP 277,550.00
Price vs 150-day SMA	38.44%
Price vs 20-day SMA	6.8%
Price vs 200-day SMA	44.46%
Price vs 50-day SMA	13.53%
Relative volume	2,000
RSI	95.07
Sharpe ratio	1.41
Sortino ratio	7.69
Weekly RSI	84.89
YTD price change	66.15%
YTD total return	71.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.58%
Short ratio	3.2 days

Deeper analysis on SNSE/ABBVCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this SNSE/ABBVCL report

Is a complete SNSE/ABBVCL research report available?

No complete published report is available for snse/ABBVCL (SNSE/ABBVCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

497T

Revenue (ttm)

59.3T

Net income (ttm)

5.8T

EPS (ttm)

CLP 3,490

P/E (trailing)

81.7x

P/E (forward)

19.1x

Dividend

CLP 6,367 (2.23%)

Metric

Value

Amount currency

CLP

Country

United States

Country code

Earnings date

2026-10-30

Employees

57,000

Employees change

5,000

Employees growth

10%

Enterprise value

CLP 560.2T

Exchange

Santiago Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

2012

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

US00287Y1091

Last earnings date

2026-07-31

Last refreshed

2026-10-28

Market cap

CLP 497T

Next earnings date

2026-10-30

Price

CLP 285,100.00

Price currency

CLP

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-27

Symbol

snse/ABBVCL

Website

https://www.abbvie.com

Metric

Value

Average P/E ratio (10Y)

41.3x

Average P/E ratio (3Y)

81.44x

Average P/E ratio (5Y)

58.76x

Earnings yield

1.22%

EV/Earnings

96.98x

EV/EBIT

24.92x

EV/EBITDA

18.31x

EV/FCF

33.39x

EV/Sales

8.86x

FCF / EV yield

2.99%

FCF yield

3.38%

Forward P/E

19.06x

Lynch fair value

CLP 16,567.50

Lynch upside

-94.19%

P/(FCF - SBC) ratio

31.3x

P/(OCF - SBC) ratio

29.11x

P/E ratio

81.68x

P/FCF ratio

29.63x

P/OCF ratio

27.66x

P/S ratio

8.38x

Price/EBITDA ratio

17.54x

Metric

Value

EBIT margin

35.56%

EBITDA margin

47.78%

Effective tax rate

27.39%

FCF margin

26.43%

Gross margin

72.79%

Operating margin

35.56%

Pretax margin

13.51%

Profit margin

9.8%

Profit per employee

CLP 101.3M

Profitable quarters

Profitable years

Revenue per employee

CLP 1B

ROA

10.51%

ROA (5Y)

8.68%

ROCE

24.49%

ROE (5Y)

1,295.17%

ROIC

17.7%

ROIC (5Y)

21.99%

SBC / revenue

1.52%

Tax / revenue

3.7%

Metric

Value

EPS growth

68.54%

EPS growth (Q)

290.39%

EPS growth (QoQ)

422.72%

EPS growth 10Y

0.21%

EPS growth 3Y

-10.05%

EPS growth 5Y

-0.92%

EPS growth quarters

EPS growth years

FCF growth

-0.16%

FCF growth (Q)

-36.24%

FCF growth (QoQ)

-12.63%

FCF growth 3Y

-9.78%

FCF growth 5Y

-1.43%

Gross profit growth

12.78%

Gross profit growth (Q)

14.64%

Gross profit growth 3Y

5.88%

Gross profit growth 5Y

5.07%

Net income growth

67.69%

Net income growth (Q)

285.18%

Net income growth (QoQ)

424.16%

Net income growth 3Y

-10.12%

Net income growth 5Y

-1.02%

Net income growth quarters

Net income growth years

OCF growth

1.16%

OCF growth (Q)

-33.32%

OCF growth (QoQ)

-10.26%

OCF growth 10Y

9.1%

OCF growth 3Y

-8.59%

OCF growth 5Y

-0.94%

Operating income growth

21.17%

Operating income growth (Q)

17.54%

Operating income growth 3Y

3.56%

Operating income growth 5Y

3.75%

Revenue growth

10.39%

Revenue growth (Q)

10.16%

Revenue growth (QoQ)

13.25%

Revenue growth 10Y

10.03%

Revenue growth 3Y

4.75%

Revenue growth 5Y

3.69%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

CLP -1.2T

Depreciation and amortization

CLP 7.8T

EBIT

CLP 21.1T

EBITDA

CLP 28.3T

EPS

CLP 3,490.29

Financing cash flow

CLP -11.9T

Free cash flow

CLP 16.8T

Free cash flow minus SBC

CLP 15.9T

Gross profit

CLP 43.2T

Income taxes

CLP 2.2T

Investing cash flow

CLP -6T

Net borrowing

CLP 412.2B

Net cash flow

CLP 94B

Net income

CLP 5.8T

Operating cash flow minus SBC

CLP 17.1T

Operating income

CLP 21.1T

Revenue

CLP 59.3T

Stock-based compensation

CLP 899.2B

Metric

Value

Altman Z-Score

2.42

Book value per share

CLP -3,094.34

Debt / EBITDA

2.28

Debt / FCF

3.89

Goodwill

CLP 35T

Interest coverage

7.85

Long-term assets

CLP 91.3T

Long-term liabilities

CLP 88.8T

Net cash (debt)

CLP -59.3T

Net cash / market cap

-11.92%

Net debt / EBITDA

2.09

Net debt / FCF

3.53

Piotroski F-Score

Property, plant and equipment

CLP 5.7T

Shareholders' equity

CLP -5.4T

Tangible book value

CLP -83.5T

Tangible book value per share

CLP -47,232.63

Total assets

CLP 124.5T

Total cash

CLP 6.1T

Total debt

CLP 65.3T

Total liabilities

CLP 129.9T

Metric

Value

Asset turnover

0.47

Current assets

CLP 33.2T

Current liabilities

CLP 41.1T

Current ratio

0.81

Inventory turnover

3.47

Net working capital

CLP -5.7T

Quick ratio

0.49

Working capital

CLP -7.3T

Working capital turnover

-6,420.13

Metric

Value

Buyback yield / dilution

-0.03%

Dividend growth

-0.52%

Dividend growth years

Dividend payment date

2026-11-16

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

CLP 6,366.78

Dividend yield

2.23%

Ex-dividend date

2026-10-15

Last dividend

CLP 1,707.18

Payout ratio

189.83%

Shareholder yield

2.21%

Metric

Value

150-day SMA

CLP 205,943.47

1D price change

2.72%

1M price change

13.23%

1M total return

13.96%

1W price change

5.95%

1W total return

5.95%

1Y price change

66.15%

1Y return CAGR

71.9%

1Y total return

71.84%

20-day SMA

CLP 266,940.50

200-day SMA

CLP 197,355.10

3M price change

20.6%

3M total return

21.37%

50-day SMA

CLP 251,131.80

50-day SMA vs 200-day SMA

50over200

52-week high

CLP 285,100.00

52-week high date

2026-10-27

52-week low

CLP 171,590.00

52-week low date

2026-07-20

6M price change

66.15%

6M total return

68.79%

All-time high

CLP 285,100.00

All-time high date

2026-10-27

All-time low

CLP 165,000.00

All-time low date

2025-04-21

Average true range (ATR)

CLP 1,807.42

Average volume

Change from 52-week high

Change from 52-week low

66.15%

Change from all-time high

Change from all-time low

72.79%

Monthly RSI

95.76

Previous close

CLP 277,550.00

Price vs 150-day SMA

38.44%

Price vs 20-day SMA

6.8%

Price vs 200-day SMA

44.46%

Price vs 50-day SMA

13.53%

Relative volume

2,000

RSI

95.07

Sharpe ratio

1.41

Sortino ratio

7.69

Weekly RSI

84.89

YTD price change

66.15%

YTD total return

71.84%

Metric

Value

Float

1.8B

Shares change (QoQ)

-0.23%

Shares change (YoY)

0.03%

Shares held by insiders

0.07%

Shares held by institutions

76.58%

Short ratio

3.2 days

SNSE/ABBVCL (SNSE/ABBVCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/ABBVCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/ABBVCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/ABBVCL

Frequently asked questions

SNSE/ABBVCL (SNSE/ABBVCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/ABBVCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/ABBVCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/ABBVCL

Frequently asked questions